SAN FRANCISCO, CA—Methotrexate is frequently under-dosed, administered for an inadequate duration, and rarely switched to subcutaneous injection prior to initiating biologic therapy, James R. O’Dell, ...
Please provide your email address to receive an email when new articles are posted on . LONDON — Patients with moderate to severe rheumatoid arthritis who receive early treatment with subcutaneous ...
Subcutaneous, Self-Administered Methotrexate for Rheumatoid Arthritis Demonstrated Significantly Gre
EWING, N.J.--(BUSINESS WIRE)-- Antares Pharma, Inc. (NAS: ATRS) today announced subcutaneous methotrexate delivered with a new, self-administration device demonstrates bioavailability that is ...
The favorable 52-week risk–benefit profile of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis merits consideration of this administration route and of an ...
Methotrexate The effectiveness of oral vs subcutaneous methotrexate for the treatment of psoriasis in a registry is reported. More patients with psoriasis who were treated with subcutaneous ...
Physicians are underutilizing methotrexate, the leading drug for rheumatoid arthritis (RA), or not keeping patients on the drug long enough before switching them to more expensive biologic drug ...
TOKYO, Sept 26, 2022 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced today that they have obtained ...
TOKYO, Feb 16, 2024 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced that they have obtained ...
Despite guidelines recommending methotrexate as a first-line treatment for patients with rheumatoid arthritis, the medication continues to be significantly underutilized by physicians in the United ...
A multicentre, prospective cohort study comparing the effectiveness of oral versus subcutaneous methotrexate in patients with early rheumatoid arthritis (RA) found subcutaneous therapy to be ...
Methotrexate is prescribed to at least 500,000 patients with rheumatoid arthritis (RA) worldwide; the best route of administration, however, is not clear. This multicenter, phase IV, randomized, ...
hands of a child with juvenile idiopathic arthritis Researchers evaluated the efficacy and safety of abatacept in pediatric patients with polyarticular-course juvenile idiopathic arthritis. ATLANTA — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback